Amgen competitors & alternatives

Amgen Inc. is a global leader in the biotechnology industry, specializing in the discovery, development, and manufacturing of human therapeutics for serious illnesses. As a pioneer in biologics, the company is frequently evaluated against other major biopharmaceutical competitors. Industry professionals and investors compare Amgen to these alternatives to assess pipeline strength, manufacturing scalability, and market share in key therapeutic areas like oncology, immunology, and cardiovascular health. Understanding these competitors is essential for stakeholders analyzing the competitive landscape of high-stakes drug development and the evolving market for complex, large-molecule therapies in the global healthcare sector.

Top Amgen competitors

Amgen competitors include Genentech, AbbVie, Biogen, Gilead Sciences and Lilly.

12 Alternatives

Genentech

Biotechnology Research and ManufacturingEnterprise

Genentech competes with Amgen in the development of complex monoclonal antibodies and targeted therapies. While Amgen focuses on large-scale biologics manufacturing, Genentech emphasizes early-stage oncology research. Buyers often choose Genentech for its deep integration with Roche’s global clinical trial network and its specialized focus on personalized medicine pipelines.

AbbVie

Biopharmaceutical DevelopmentEnterprise

AbbVie competes with Amgen in the immunology and rheumatology markets. Unlike Amgen’s broad portfolio, AbbVie leverages a highly concentrated strategy around blockbuster immunology assets. Organizations often prefer AbbVie when seeking specialized commercialization expertise in chronic disease management, whereas Amgen offers a more diversified manufacturing footprint across multiple therapeutic areas.

Biogen

Neurology-Focused BiopharmaEnterprise

Biogen competes with Amgen in the development of complex biologics for neurological conditions. Unlike Amgen’s diverse therapeutic range, Biogen maintains a narrow, deep focus on neuroscience. Investors and partners often select Biogen for its specialized expertise in neurodegenerative diseases, whereas Amgen provides broader manufacturing scale for diverse patient populations.

Gilead Sciences

Biopharmaceutical InnovationEnterprise

Gilead Sciences competes with Amgen in the antiviral and oncology sectors. While Amgen maintains a massive internal manufacturing infrastructure, Gilead often utilizes a more agile, partnership-heavy model for drug development. Buyers choose Gilead for its rapid innovation cycles in virology, contrasting with Amgen’s long-term stability in large-molecule production.

Lilly

Global Pharmaceutical ManufacturingEnterprise

Eli Lilly competes with Amgen in metabolic and endocrine therapeutic markets. While Amgen excels in protein-based biologics, Eli Lilly has recently dominated with small-molecule and peptide-based innovations. Buyers often compare these two for their manufacturing capacity, with Lilly offering a more robust pipeline in diabetes and obesity management solutions.

Unlock Full Company Details and Decision-Maker Insights

Tech stack categories related to Amgen

These categories group common types of tools used across the tech stack, helping organize platforms by their core capabilities.

Oncology Drug Pipelines

Research and development workflows for targeted cancer therapy and treatment.

Biologics Manufacturing Platforms

Large-scale production systems for complex protein-based therapeutic drug development.

Immunology Therapeutic Solutions

Development of treatments for autoimmune and inflammatory disease conditions.

Market overview

The biopharmaceutical market is defined by intense competition between firms leveraging proprietary biologics manufacturing and specialized therapeutic research. Stakeholders must evaluate competitors based on clinical trial success rates, manufacturing capacity, and the ability to navigate complex regulatory environments. Explore Amgen’s funding and financial details.

Why users choose Amgen

  • Industry-leading expertise in large-molecule biologics manufacturing
  • Extensive global supply chain and production infrastructure
  • Proven track record in long-term chronic disease management
  • Strong portfolio of established blockbuster therapeutic assets

Why users switch to alternatives

  • Need for more agile, early-stage research partnerships
  • Desire for specialized focus in niche therapeutic areas like neuroscience
  • Requirement for faster innovation cycles in small-molecule development
  • Seeking alternative pricing models for high-cost biologics
  • Preference for companies with different clinical trial geographic footprints

Discover competitor landscapes for other companies

Binance
Cryptocurrency Exchange PlatformEnterprise

Binance is a global cryptocurrency exchange that provides a comprehensive platform for trading hundreds of digital assets, derivatives, and decentralized finance services. As the industry leader in trading volume, it is frequently evaluated by users seeking alternatives that offer different regulatory profiles, specialized trading tools, or specific regional accessibility. Whether you are comparing Binance to competitors for enhanced security, lower fees, or specific altcoin availability, understanding the landscape of crypto exchange alternatives is essential for optimizing your trading strategy. This guide helps you compare Binance against top-tier platforms to determine which exchange best aligns with your specific investment goals and risk tolerance.

School of Medicine and Public Health
Medical Education and ResearchEnterprise

The University of Wisconsin School of Medicine and Public Health is a premier institution dedicated to medical education, research, and public health service. As a leader in the Wisconsin Idea, it bridges the gap between academic discovery and community health outcomes. Prospective students and researchers often compare the School of Medicine and Public Health to other top-tier medical schools and alternatives to evaluate clinical training quality, research funding, and public health impact. Understanding these competitors helps stakeholders identify the best environment for their specific medical career goals, whether they prioritize community-based public health or large-scale, specialized clinical research environments.

Grupo De Inv Suramericana
Real Estate Development FirmEnterprise

Grupo De Inv Suramericana operates as a prominent real estate development firm, focusing on the strategic acquisition, development, and management of high-value property assets. As investors and homebuyers seek the best alternatives for capital appreciation and residential quality, they often compare the firm against other major developers in the region. Understanding these competitors is essential for evaluating market positioning, project reliability, and investment potential. This analysis provides a clear view of the competitive landscape, helping stakeholders compare services, project portfolios, and development capabilities to make informed decisions in the dynamic real estate market.

Azot, PJSC, OSTCHEM Group
Nitrogen Fertilizer ManufacturerEnterprise

Azot, part of the OSTCHEM Group, is a major player in the nitrogen fertilizer manufacturing industry, providing essential chemical products for agriculture and industrial applications. As market demands shift toward sustainable production and global supply chain efficiency, many organizations compare Azot with international competitors to evaluate product quality, logistics reliability, and pricing. Whether you are looking for alternatives to optimize your supply chain or seeking specialized nitrogen-based solutions, understanding how Azot stacks up against global industry leaders is critical. This analysis helps you compare key market players, evaluate their unique value propositions, and identify the best partners for your specific agricultural or industrial chemical requirements.

HGTECH
Industrial Laser SolutionsEnterprise

HGTECH Co is a leading provider of industrial laser solutions, specializing in laser cutting, welding, and marking systems for the manufacturing sector. As companies seek to optimize production efficiency and precision, they often compare HGTECH against global and regional competitors to find the best balance of performance, cost, and technical support. Whether you are looking for high-power fiber laser systems or automated manufacturing lines, evaluating alternatives is essential for aligning your capital investment with specific production needs. This guide helps you compare HGTECH with top industry players to determine which provider best fits your operational requirements and long-term manufacturing goals.

City of Raleigh
Municipal Government ServicesEnterprise

The City of Raleigh serves as the capital of North Carolina, providing essential municipal services, public infrastructure, and community governance to its residents. As a hub for the Research Triangle, it is frequently evaluated alongside other major municipalities that offer similar public services, economic development programs, and quality-of-life metrics. Residents, businesses, and prospective employees often search for competitors or alternatives to understand how Raleigh’s governance, tax structure, and public utility efficiency compare to other regional and national cities. This analysis helps stakeholders make informed decisions regarding relocation, business expansion, and civic engagement by contrasting Raleigh’s specific municipal offerings with those of comparable urban centers.

Frequently Asked Questions About Amgen Competitors

Who are the main competitors of Amgen?
The main competitors of Amgen include Genentech, AbbVie, and Biogen. Each competitor links to its company profile page.
What are some alternatives to Amgen?
Alternatives to Amgen include companies such as Biogen, Gilead Sciences, and Lilly.
Which companies compete with Amgen?
Other companies that compete with Amgen include Lilly.